Information Provided By:
Fly News Breaks for April 26, 2016
WAT
Apr 26, 2016 | 14:00 EDT
Cantor Fitzgerald analyst Bryan Brokmeier views Waters' Q1 report as strong and believes the lower than expected operating expenses it reported indicated that the company may have more margin expansion potential than recognized. The company's raised guidance is conservative and the there aren't any signs of weakness in the biopharma market from Waters or peers despite investor concerns, said Brokmeier. The analyst keeps a Buy rating and $163 price target on Waters shares.
News For WAT From the Last 2 Days
There are no results for your query WAT
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.